ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.208,96
0,40%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Novus Therapeutics Inc (NVUS)

  7. Novus Therapeutics Inc (NVUS) Notícias

NVUS

Novus Therapeutics (NVUS)

Novus Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVUS
DataHoraFonteTítuloCódigoCompanhia
22/06/202307:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
08/06/202317:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVUSNovus Therapeutics Inc
05/06/202307:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVUSNovus Therapeutics Inc
22/05/202314:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NVUSNovus Therapeutics Inc
18/05/202318:16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NVUSNovus Therapeutics Inc
11/05/202318:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVUSNovus Therapeutics Inc
02/05/202319:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202317:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202317:49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVUSNovus Therapeutics Inc
24/03/202218:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVUSNovus Therapeutics Inc
14/02/202217:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVUSNovus Therapeutics Inc
21/05/202118:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:NVUSNovus Therapeutics Inc
20/04/202108:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVUSNovus Therapeutics Inc
12/04/202107:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVUSNovus Therapeutics Inc
16/02/202118:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVUSNovus Therapeutics Inc
05/01/202118:39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVUSNovus Therapeutics Inc
22/12/202018:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:NVUSNovus Therapeutics Inc
13/11/202019:05Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NVUSNovus Therapeutics Inc
02/11/202010:00Business WireNovus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic ...NASDAQ:NVUSNovus Therapeutics Inc
23/10/202018:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVUSNovus Therapeutics Inc
02/10/202012:00Business WireNovus Therapeutics Announces One-for-Eighteen Reverse Stock SplitNASDAQ:NVUSNovus Therapeutics Inc
15/09/202017:56Business WireNovus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment ConferencesNASDAQ:NVUSNovus Therapeutics Inc
14/09/202017:31Business WireNovus Therapeutics Announces Acquisition of Anelixis TherapeuticsNASDAQ:NVUSNovus Therapeutics Inc
25/03/202017:07Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVUSNovus Therapeutics Inc
20/02/202008:12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:NVUSNovus Therapeutics Inc
22/07/201907:00GlobeNewswire Inc.Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB MarketNASDAQ:NVUSNovus Therapeutics Inc
01/05/201907:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NVUSNovus Therapeutics Inc
30/04/201917:11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVUSNovus Therapeutics Inc
07/09/201810:02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVUSNovus Therapeutics Inc
04/09/201817:40Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NVUSNovus Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVUS

Seu Histórico Recente

NASDAQ
GLDI
Credit Suisse X Links Go...
BOV
BMIN4Q
MERC INVEST PN
TSXV
NKW
Oceanic Wind Energy
LSE
0IJW
Extreme Networks
BOV
ENEVE130
ENEVE130 Ex:13
NYSE
IDR
Intrawest
BOV
PMAM3M
PARANAPANEMA ON
LSE
ESP
Empiric Student Property
NYSE
WAIR
Wesco Aircraft
NYSE
FEI
First Trust MLP and Ener...
BOV
ETER3Q
ETERNIT ON
LSE
0IFA
Ecolab
LSE
0QX7
Energa
LSE
0OG9
Exclusive Property Adsit...
NYSE
SLQT
SelectQuote
LSE
0QQ1
Enr Russia Invest
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados